Artal Group’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Artal Group’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-79,600	Closed	-$1.15M	–	161
2021 Q2	$1.15M	Hold	79,600	–	–	0.02%	141
2021 Q1	$343K	Hold	79,600	–	–	0.01%	145
2020 Q4	$450K	Buy	+79,600	New	+$321K	0.01%	129

Artal Group's CEREW Position: Q3 2021 in Review

Artal Group sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 79,600 shares — an estimated $1.15M sold.

Artal Group first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $1.15M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Artal Group reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Artal Group sold 79,600 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $1.15M.
Artal Group first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Artal Group's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $1.15M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Artal Group's 13F filing for Q3 2021, filed 12 Nov 2021.